CliffBio
small molecule

KLOXXADO

NALOXONE HYDROCHLORIDE

Loss of exclusivityAugust 2034latest FDA-listed patent expiry
CompanyHikma →View the full company profile on CliffBio

Drug detail

Brand nameKLOXXADO
Active ingredientNALOXONE HYDROCHLORIDE
Strength8MG/SPRAY
Dosage formSPRAY
RouteNASAL
ModalitySmall molecule
FDA approvalApril 2021
Marketing statusRX

Listed patents

PatentExpiresType
11617713August 2034product
11628139August 2034product
10973814August 2034product
10722510August 2034product
11975096August 2034product
12414915August 2034product
11135155August 2034product

More from Hikma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

KLOXXADO patent cliff — loss of exclusivity August 2034 | CliffBio